← Leaderboards
Bradley Lether Pentelute
Massachusetts Institute Of Technology
$2,969,152
Attributed
$4,451,350
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $717.2K · FY2014–23$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,451,350 · 2
By mechanism
R01$4,451,350 · 2
Top collaborators
- Sean Edward Lawler6 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Ronald T Raines$23,937,707
- Graham C Walker$23,287,427
- Stephen J Haggarty$15,636,814
- Joanne Stubbe$16,578,287
- Nikolaos Mellios$3,149,348
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesChemistryFluorineDesignModificationPharmaceutical PreparationsPenetrationToxic EffectEngineeringProtein Protein InteractionBiologicalVariantCellsMdm2 GeneBaseTp53 GenePeptide DrugBindingInhibitor/AntagonistBlood - Brain Barrier AnatomyBiologyAreaAntineoplastic AgentsAffect
Grant awards (12)
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment$511,916
R01 · FY2023 · CA
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment$516,442
R01 · FY2022 · CA
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment$441,111
R01 · FY2021 · CA
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment$276,125
R01 · FY2021 · CA
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment$599,526
R01 · FY2020 · CA
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment$619,276
R01 · FY2019 · CA
Cysteine Arylation$261,193
R01 · FY2018 · GM · contact PI
Cysteine Arylation$262,870
R01 · FY2017 · GM · contact PI
Cysteine Arylation$165,000
R01 · FY2017 · GM · contact PI
Cysteine Arylation$264,467
R01 · FY2016 · GM · contact PI
Cysteine Arylation$265,988
R01 · FY2015 · GM · contact PI
Cysteine Arylation$267,436
R01 · FY2014 · GM · contact PI